Synopsis
The pandemic has catapulted India to the high table of global health diplomacy. Using its position as the world’s leading supplier of vaccines and medicines, it has wielded its soft power to great effect, grabbing significant political clout internationally. In this backdrop, what are the salient aspects that India needs to consider to consolidate its position further?
The coronavirus pandemic, described by the World Health Organisation (WHO) as a “health emergency”, upended public-health projections and exposed the fragility of healthcare ecosystems, particularly in the global south. On the one hand, India used soft power and global pharmaceutical dominance, backed by effective state policy, to deal with the situation. On the other, China’s vaccine certification and supply since 2015 under the WHO banner came
BY
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Minimal Ads
Comment & Engage with ET Prime community 
Exclusive invites to Virtual Events with Industry Leaders 
A trusted team of Journalists & Analysts who can best filter signal from noise 
Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-
